HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

GSK215083

a PET radioligand for 5-HT6 receptor; structure in first source

Also Known As:

11C-GSK215083

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - GSK215083: 2
Organic Chemicals: 133
- Sulfur Compounds: 278
  - Sulfones: 534
    - GSK215083: 2

Experts

1.	Carson, Richard E: 1 article (01/2020)
2.	D'Souza, Deepak Cyril: 1 article (01/2020)
3.	Gaiser, Edward: 1 article (01/2020)
4.	Gallezot, Jean-Dominique: 1 article (01/2020)
5.	Henry, Shannan: 1 article (01/2020)
6.	Huang, Yiyun: 1 article (01/2020)
7.	Lin, Shu-Fei: 1 article (01/2020)
8.	Matuskey, David: 1 article (01/2020)
9.	Nabulsi, Nabeel: 1 article (01/2020)
10.	Planeta, Beata: 1 article (01/2020)

Related Diseases

1.	Schizophrenia (Dementia Praecox) 01/01/2020 - "In vivo 5-HT6 and 5-HT2A receptor availability in antipsychotic treated schizophrenia patients vs. unmedicated healthy humans measured with [11C]GSK215083 PET."
2.	Alzheimer Disease (Alzheimer's Disease) 12/01/2015 - "Human Kinetic Modeling of the 5HT6 PET Radioligand 11C-GSK215083 and Its Utility for Determining Occupancy at Both 5HT6 and 5HT2A Receptors by SB742457 as a Potential Therapeutic Mechanism of Action in Alzheimer Disease."

Related Drugs and Biologics

1.	5-HT2A Serotonin Receptor (5 HT2A Receptor)
2.	Antipsychotic Agents (Antipsychotics)
3.	3- benzenesulfonyl- 8- piperazin- 1- ylquinoline